Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “vaccine”

821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 821
Index total 30,257
Page 10 / 35

Quick answer

This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

821 results for “vaccine” · 30,257 patents in full index Clear search

  1. US 10835597

    Compositions and methods for stabilizing flaviviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  2. US 10828364

    Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  3. US 10829550

    Polynucleotides encoding anti-CXCL13 antibodies

    VACCINEX, INC. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  4. US 10821163

    Process for the production of a DNA vaccine for cancer immunotherapy

    Vaximm AG · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  5. US 10806782

    Hand, foot, and mouth vaccines and methods of manufacture and use thereof

    Takeda Vaccines, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  6. US 10806781

    Compositions and methods for live, attenuated alphavirus formulations

    Takeda Vaccines, Inc. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

  7. US 10799573

    Pertussis vaccines and methods of making and using

    Regents of the University of Minnesota · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  8. US 10799576

    RSV vaccines and methods of production and use thereof

    The Board of Regents for Oklahoma State University · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  9. US 10800853

    Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

    VACCINEX, INC. · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  10. US 10792353

    Virus like particle purification

    Takeda Vaccines, Inc. · Granted Oct 6, 2020 · Expires Oct 1, 2040

    granted

  11. US 10780155

    Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, Streptococcus vaccines, and methods for making and using them

    The Regents of the University of California · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  12. US 10774334

    Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  13. US 10751408

    Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted

  14. US 10724007

    Development of dengue virus vaccine components

    The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  15. US 10688174

    Method of conferring a protective immune response to norovirus

    Takeda Vaccines, Inc. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  16. US 10675341

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  17. US 10660947

    Vaccine composition

    TURNSTONE LIMITED PARTNERSHIP · Granted May 26, 2020 · Expires May 21, 2040

    granted

  18. US 10646557

    Vaccine composition

    TURNSTONE LIMITED PARTNERSHIP · Granted May 12, 2020 · Expires May 7, 2040

    granted

  19. US 10646438

    Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine

    The Board of Regents of the University of Texas System · Granted May 12, 2020 · Expires May 7, 2040

    granted

  20. US 10632184

    Compositions and methods for stabilizing alphaviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  21. US 10604548

    Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  22. US 10596247

    Methods and compositions for attenuated chlamydia as vaccine and vector

    The Board of Regents of the University of Texas System · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  23. US 10584355

    Chimpanzee adenoviral vector-based filovirus vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Mar 10, 2020 · Expires Mar 5, 2040

    granted

  24. US 10561724

    Live attenuated virus vaccines for La Crosse virus and other bunyaviridae

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.